Factors associated with unplanned clinical encounters for ureteral stent-related symptoms.
Acute renal colic
Nephrolithiasis
Opioid analgesics
Stent colic
Ureteral stent
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
07 Feb 2024
07 Feb 2024
Historique:
received:
05
04
2023
accepted:
02
01
2024
medline:
7
2
2024
pubmed:
7
2
2024
entrez:
7
2
2024
Statut:
epublish
Résumé
Ureteral stent-related symptoms (USRS) often result in unplanned phone calls and ER visits. We hypothesize that patient factors can be identified to predict these unplanned encounters. Retrospective analysis of indwelling ureteral stent placements from 2014 to 2019 at a single institution by CPT code was performed. Patient demographics, discharge medications, and clinical factors were evaluated using multiple logistic regression with respect to postoperative telephone and emergency room (ER) encounters for USRS. Of 374 patients, 75 (20.1%) had one or more encounters for USRS: 48 (12.8%) called the clinic and 39 (10.4%) returned to the ER. Chronic opioid use was predictive of calls to clinic and ER visits (OR 3.21 [CI 1.42-6.97], p < 0.01 and OR 3.64 [CI 1.45-8.98], p < 0.01). Survival analysis stratified by history of chronic opioid use and discharge opioid prescriptions demonstrated that opioid naïve patients receiving opioids at discharge had unplanned encounters sooner and more often [Calls p = 0.025, ER p = 0.041]), whereas patients with chronic opioid use returned to the ER sooner and more frequently when prescribed additional opioids (Calls p = 0.4, ER p = 0.002). Patients with a history of chronic opioid use may experience more intense USRS or have a lower threshold to seek medical care than opioid naïve patients and tend to bypass calling the clinic for the ER. Given that none of the studied medications reduced unplanned patient contact for USRS, urologists should consider upfront definitive management of urinary obstruction when appropriate.
Sections du résumé
BACKGROUND, INTRODUCTION AND AIM
UNASSIGNED
Ureteral stent-related symptoms (USRS) often result in unplanned phone calls and ER visits. We hypothesize that patient factors can be identified to predict these unplanned encounters.
METHODS AND MATERIALS
METHODS
Retrospective analysis of indwelling ureteral stent placements from 2014 to 2019 at a single institution by CPT code was performed. Patient demographics, discharge medications, and clinical factors were evaluated using multiple logistic regression with respect to postoperative telephone and emergency room (ER) encounters for USRS.
RESULTS
RESULTS
Of 374 patients, 75 (20.1%) had one or more encounters for USRS: 48 (12.8%) called the clinic and 39 (10.4%) returned to the ER. Chronic opioid use was predictive of calls to clinic and ER visits (OR 3.21 [CI 1.42-6.97], p < 0.01 and OR 3.64 [CI 1.45-8.98], p < 0.01). Survival analysis stratified by history of chronic opioid use and discharge opioid prescriptions demonstrated that opioid naïve patients receiving opioids at discharge had unplanned encounters sooner and more often [Calls p = 0.025, ER p = 0.041]), whereas patients with chronic opioid use returned to the ER sooner and more frequently when prescribed additional opioids (Calls p = 0.4, ER p = 0.002).
CONCLUSION
CONCLUSIONS
Patients with a history of chronic opioid use may experience more intense USRS or have a lower threshold to seek medical care than opioid naïve patients and tend to bypass calling the clinic for the ER. Given that none of the studied medications reduced unplanned patient contact for USRS, urologists should consider upfront definitive management of urinary obstruction when appropriate.
Identifiants
pubmed: 38324162
doi: 10.1007/s00345-024-04768-x
pii: 10.1007/s00345-024-04768-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
74Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Chen Y-T, Chen J, Wong W-Y, Yang SS-D, Hsieh C-H, Wang C-C (2002) Is ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy? A prospective, randomized controlled trial. J Urol 167(5):1977–1980
doi: 10.1016/S0022-5347(05)65066-5
pubmed: 11956421
Ho C-H, Tai H-C, Chang H-C, Fu-Chang Hu, Chen S-C, Lee Y-J, Chen J, Huang K-H (2010) Predictive factors for ureteral double-j-stent-related symptoms: a prospective, multivariate analysis. J Formos Med Assoc 109(11):848–856. https://doi.org/10.1016/s0929-6646(10)60130-1
doi: 10.1016/s0929-6646(10)60130-1
pubmed: 21126657
Denstedt JD, Wollin TA, Sofer M, Nott L, Weir M, D’A Honey RJ (2001) A prospective randomized controlled trial comparing nonstented versus stented ureteroscopic lithotripsy. J Urol 165(5):1419–1422
doi: 10.1016/S0022-5347(05)66320-3
pubmed: 11342889
Borboroglu PG, Amling CL, Schenkman NS, Monga M, Ward JF, Piper NY, Bishoff JT, Kane CJ (2001) Ureteral stenting after ureteroscopy for distal ureteral calculi: a multi-institutional prospective randomized controlled study assessing pain, outcomes and complications. J Urol 166(5):1651–1657. https://doi.org/10.1016/s0022-5347(05)65646-7
doi: 10.1016/s0022-5347(05)65646-7
pubmed: 11586195
Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX, Timoney AG (2003) Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 169(3):1060–1064. https://doi.org/10.1097/01.ju.0000049198.53424.1d
doi: 10.1097/01.ju.0000049198.53424.1d
pubmed: 12576846
Joshi HB, Okeke A, Newns N, Keeley FX, Timoney AG (2002) Characterization of urinary symptoms in patients with ureteral stents. Urology 59(4):511–516. https://doi.org/10.1016/s0090-4295(01)01644-2
doi: 10.1016/s0090-4295(01)01644-2
pubmed: 11927301
Ucuzal M, Serçe P (2017) Ureteral stents. Holist Nurs Pract 31(2):126–132. https://doi.org/10.1097/hnp.0000000000000200
doi: 10.1097/hnp.0000000000000200
pubmed: 28181978
Monga M, Miyaoka R (2009) Ureteral stent discomfort: Etiology and management. Indian J Urol 25(4):455. https://doi.org/10.4103/0970-1591.57910
doi: 10.4103/0970-1591.57910
pubmed: 19955667
pmcid: 2808646
Mittakanti HR, Conti SL, Pao AC, Chertow GM, Liao JC, Leppert JT, Elliott CS (2018) Unplanned emergency department visits and hospital admissions following ureteroscopy: do ureteral stents make a difference? Urology 117:44–49. https://doi.org/10.1016/j.urology.2018.03.019
doi: 10.1016/j.urology.2018.03.019
pubmed: 29601836
Zimskind PD, Fetter TR, Wilkerson JL (1967) Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 97(5):840–844. https://doi.org/10.1016/s0022-5347(17)63130-6
doi: 10.1016/s0022-5347(17)63130-6
pubmed: 6025928
Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, Pace KT, Pais VM, Pearle MS, Preminger GM, Razvi H, Shah RO, Matlaga B (2016) Surgical management of stones: american urological association/endourological society guideline, PART II. J Urol 196(4):1161–1169. https://doi.org/10.1016/j.juro.2016.05.091
doi: 10.1016/j.juro.2016.05.091
pubmed: 27238615
Kirshenbaum EJ, Doshi C, Dornbier R, Blackwell RH, Bajic P, Gupta GN, Gorbonos A, Turk TMT, Flanigan RC, Baldea KG (2019) Socioeconomic disparities in the acute management of stone disease in the United States. J Endourol 33(2):167–172. https://doi.org/10.1089/end.2018.0760
doi: 10.1089/end.2018.0760
pubmed: 30612434
Navetta AF, Elmekresh A, Doersch K, Durdin TD, Machen GL, Cohen A, Lowry PS, El Tayeb MM (2019) Preoperative ureteral stenting prior to ureteroscopy for management of urolithiasis does not impact the postoperative return for unplanned care. Urol Ann 11(3):282–286. https://doi.org/10.4103/UA.UA_78_18
doi: 10.4103/UA.UA_78_18
pubmed: 31413507
pmcid: 6676851
Large T, Heiman J, Ross A, Anderson B, Krambeck A (2018) Initial experience with narcotic-free ureteroscopy: a feasibility analysis. J Endourol 32(10):907–911. https://doi.org/10.1089/end.2018.0459
doi: 10.1089/end.2018.0459
pubmed: 30039709
Netsch C, Knipper S, Bach T, Herrmann TRW, Gross AJ (2012) Impact of preoperative ureteral stenting on stone-free rates of ureteroscopy for nephroureterolithiasis: a matched-paired analysis of 286 patients. Urology 80(6):1214–1220. https://doi.org/10.1016/j.urology.2012.06.064
doi: 10.1016/j.urology.2012.06.064
pubmed: 23084830
Du K, Wang RS, Vetter J, Paradis AG, Figenshau RS, Venkatesh R, Desai AC (2018) Unplanned 30-Day encounters after ureterorenoscopy for urolithiasis. J Endourol 32(12):1100–1107. https://doi.org/10.1089/end.2018.0177
doi: 10.1089/end.2018.0177
pubmed: 30156428
Makris K, Spanou L (2016) Acute kidney injury: definition, pathophysiology and clinical phenotypes. Clin Biochem 37(2):85–98
Ordonez M, Chang Hwang E, Michael Borofsky J, Bakker C, Gandhi S, Dahm P (2019) Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd012703.pub2
doi: 10.1002/14651858.cd012703.pub2
pubmed: 30726554
pmcid: 6365118
Gridley C, Robles J, Calvert J, Kavoussi N, Winkler T, Jayaram J, Fosnot M, Liberman J, Allen B, McEvoy M, Herrell D, Hsi R, Miller NL (2020) Enhanced recovery after surgery protocol for patients undergoing ureteroscopy: prospective evaluation of an opioid-free protocol. J Endourol 34(6):647–653. https://doi.org/10.1089/end.2019.0552
doi: 10.1089/end.2019.0552
pubmed: 31928086
Sobel DW, Cisu T, Barclay T, Pham A, Callas P, Sternberg K (2018) A retrospective review demonstrating the feasibility of discharging patients without opioids after ureteroscopy and ureteral stent placement. J Endourol 32(11):1044–1049. https://doi.org/10.1089/end.2018.0539
doi: 10.1089/end.2018.0539
pubmed: 30244594
Byrne RR, Auge BK, Kourambas J, Munver R, Delvecchio F, Preminger GM (2002) Routine ureteral stenting is not necessary after ureteroscopy and ureteropyeloscopy: a randomized trial. J Endourol 16(1):9–13. https://doi.org/10.1089/089277902753483646
doi: 10.1089/089277902753483646
pubmed: 11890453
Bower PE, Pereira J, Al-Alao O, Kott O, Velez D, Thavaseelan S, Pareek G (2019) Indications for stent omission after ureteroscopic lithotripsy defined: a single-institution experience with cost analysis. Arab J Urol 17(3):206–211. https://doi.org/10.1080/2090598x.2019.1614243
doi: 10.1080/2090598x.2019.1614243
pubmed: 31489236
pmcid: 6711146
Fischer KM, Louie M, Mucksavage P (2018) Ureteral stent discomfort and its management. Curr Urol Rep. https://doi.org/10.1007/s11934-018-0818-8
doi: 10.1007/s11934-018-0818-8
pubmed: 29892783
Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Athanasios Dellis M, Varkarakis I (2006) Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 67(1):35–39. https://doi.org/10.1016/j.urology.2005.07.038
doi: 10.1016/j.urology.2005.07.038
pubmed: 16413328
Damiano R, Autorino R, De Sio M, Giacobbe A, Palumbo IM, D’Armiento M (2008) Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 22(4):651–656. https://doi.org/10.1089/end.2007.0257
doi: 10.1089/end.2007.0257
pubmed: 18338955
Park SC, Jung SW, Lee JW, Rim JS (2009) The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms. J Endourol 23(11):1913–1917. https://doi.org/10.1089/end.2009.0173
doi: 10.1089/end.2009.0173
pubmed: 19814699
El-Nahas AR, Tharwat M, Elsaadany M, Mosbah A, Gaballah MA (2016) A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms. World J Urol 34(7):963–968. https://doi.org/10.1007/s00345-015-1704-3
doi: 10.1007/s00345-015-1704-3
pubmed: 26453222
Richard Beddingfield N, Pedro R, Hinck B, Kreidberg C, Feia K, Monga M (2009) Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol 181(1):170–176. https://doi.org/10.1016/j.juro.2008.09.026
doi: 10.1016/j.juro.2008.09.026
pubmed: 19013590
Taek Lim K, Tae Kim Y, Yong Lee T, Yul Park S (2011) Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean J Urol 52(7):485. https://doi.org/10.4111/kju.2011.52.7.485
doi: 10.4111/kju.2011.52.7.485
García-Perdomo HA, Echeverría-García F, López H, Fernández N, Manzano-Nunez R (2017) Pharmacologic interventions to treat renal colic pain in acute stone episodes: systematic review and meta-analysis. Prog Urol 27(12):654–665. https://doi.org/10.1016/j.purol.2017.05.011
doi: 10.1016/j.purol.2017.05.011
pubmed: 28651994
Association AU (2019) AUA Position Statement: Opioid Use
Koo K, Faisal F, Gupta N, Meyer AR, Patel HD, Pierorazio PM, Matlaga BR, Allaf ME, Gorin MA, Gupta M, Han M, Johnson MH, Padilla A, Pavlovich CP, Sharpe W (2020) Recommendations for opioid prescribing after endourological and minimally invasive urological surgery: an expert panel consensus. J Urol 203(1):151–158. https://doi.org/10.1097/ju.0000000000000514
doi: 10.1097/ju.0000000000000514
pubmed: 31464563